Foley Partner Recognized at 2019 Intellectual Property Owners Association (IPO) Annual Meeting
September 26, 2019
In recognition of exceptional service, Partner Eley Thompson and fellow members of the IPO Litigation Committee received the Outstanding Committee of the Year Award at IPO’s 47th Annual Meeting in Washington, DC. The award was presented during the keynote session on Thursday, September 26th.
Each year, the IPO Annual Meeting brings together IP professionals from corporations, law firms, government, academia, and service providers from around the world to discuss industry strategies, trends, and best practices.
For more information about IPO and the Annual Meeting, please visit the IPO website.
Each year, the IPO Annual Meeting brings together IP professionals from corporations, law firms, government, academia, and service providers from around the world to discuss industry strategies, trends, and best practices.
For more information about IPO and the Annual Meeting, please visit the IPO website.
People
Related News
March 4, 2026
In the News
Christopher Ward Analyzes Uncertain Future of State Captive‑Audience Laws
Foley & Lardner LLP partner Christopher Ward was quoted in the Law360 article, “State Captive Audience Bans Live On Despite Uncertainty,” analyzing the legal status and future prospects for state laws restricting captive audience meetings.
March 3, 2026
In the News
Patrick Daugherty Assesses Growing Popularity of Crypto ATMs
Foley & Lardner LLP partner Patrick Daugherty assessed the growing popularity of crypto ATMs in the C-Store Dive article, “Navigating the pros and cons of crypto ATMs for convenience retailers.”
March 3, 2026
In the News
Judith Waltz Weighs CMS Anti‑Fraud Tools, Provider Screening, and Moratorium Risks
Foley & Lardner LLP partner Judith Waltz was quoted in the Report on Medicare Compliance article, “Attestation May Send Some PBDs Packing; 'They May Find Things Have Eroded Over Time'” discussing the evolving anti-fraud ecosystem, the Centers for Medicare & Medicaid Services' (CMS) forthcoming provider screening tool, and benefits of moratorium.